We wanted to share the most amazing news, from the Alzheimers Society, that’s just come out of the US – Biogen is filing for the approval of a new treatment for early stage Alzheimer’s disease. This is potentially the first new dementia drug in 15 years! Dr James Pickett, Alzheimer’s Society Head of Research said: “Alzheimer’s Society has a proud history of funding dementia research, including critical discoveries that have made today’s news possible. We will work alongside the company, regulators and people affected by dementia to understand the difference this could make to families and, if appropriate, to ensure people can benefit from this medical breakthrough in the future..” Listen to the latest here
